Dr Elizabeth Moore is Research Fellow and Project Manager of the Myeloma and Related Diseases Registry (MRDR) in the SPHPM, and has been heavily involved in the growth and increasing productivity of the registry and the Myeloma 1000 Biobank. She is investigator on various MRDR-based projects including the MRFF-funded epidemiological modelling study to anticipate future needs and deliver better care for Australians with multiple myeloma, and the IMPROVE study to describe immunoglobulin use, and inform policy and future stewardship of this resource in Australia. She also provides support to an expanding and diverse range of MRDR studies http://www.mrdr.net.au/projects/.

Elizabeth led the My-PROMPT trial, a randomised controlled trial to test the feasibility of real-time feedback of patient-reported outcomes (PROs) to clinicans treating patients with multiple myeloma. This was the first trial of its kind in a cohort with blood cancer and results informed the recently MRFF-funded MY-PROMPT-2 trial assessing whether real-time feedback of PROs to clinicians improves duration on therapy in patients with relapsed myeloma receiving standard of care, compared to standard of care alone.

Elizabeth has extensive experience managing the complex needs of critically ill cancer patients as a critical care nurse, is a current member of the Research Standing Committee of the Cancer Nurses Society of Australia (CNSA) and the Research Advisory Panel of the Australian College of Critical Care Nurses (ACCCN), and has been a member of the ACCCN Victorian Management Committee (2012-2018). She is a current member of the Research Governance Committee for the SPHPM.

She reviews applications for the ACCCN and ANZ Intensive Care Foundation grants, abstracts for the CNSA Annual Congress and the joint ANZ Intensive Care Society-ACCCN Annual Scientific Meeting, and participates in PhD graduate review panels in the School of Public Health and Preventive Medicine. She has reviewed manuscripts for numerous journals including Cancer Medicine and Lancet Haematology.

Research Projects

Myeloma and Related Diseases Registry   http://www.mrdr.net.au/

My-PROMPT: Patient Reported Outcome Measures in multiple myeloma: real-time rePorTing to improve care   http://www.mrdr.net.au/projects/

IMPROVE: Immunoglobulins in Myeloma Patients: Research into Outcomes, Variation in practice, and Epidemiology   http://www.mrdr.net.au/projects/

Asia-Pacific Myeloma and Related Diseases Registry (APAC MRDR)   https://apacmrdr.org/